Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6773 | 1445 | 45.5 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
124 | 3 | PARKINSONS DISEASE//MOVEMENT DISORDERS//DEEP BRAIN STIMULATION | 67777 |
332 | 2 | PARKINSONS DISEASE//ALPHA SYNUCLEIN//PARKIN | 18089 |
6773 | 1 | LRRK2//LEUCINE RICH REPEAT KINASE 2//LEUCINE RICH REPEAT KINASE 2 LRRK2 | 1445 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LRRK2 | authKW | 6227851 | 25% | 81% | 365 |
2 | LEUCINE RICH REPEAT KINASE 2 | authKW | 1198062 | 4% | 90% | 63 |
3 | LEUCINE RICH REPEAT KINASE 2 LRRK2 | authKW | 827972 | 3% | 85% | 46 |
4 | PARK8 | authKW | 826034 | 3% | 95% | 41 |
5 | G2019S | authKW | 676781 | 2% | 97% | 33 |
6 | DARDARIN | authKW | 455382 | 2% | 86% | 25 |
7 | ATP13A2 | authKW | 368111 | 2% | 62% | 28 |
8 | PARKINSONS DISEASE | authKW | 349320 | 49% | 2% | 704 |
9 | G2019S MUTATION | authKW | 253561 | 1% | 100% | 12 |
10 | KUFOR RAKEB SYNDROME | authKW | 223181 | 1% | 81% | 13 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 8033 | 33% | 0% | 476 |
2 | Neurosciences | 5799 | 38% | 0% | 543 |
3 | Genetics & Heredity | 2363 | 18% | 0% | 257 |
4 | Biochemistry & Molecular Biology | 1058 | 26% | 0% | 370 |
5 | Geriatrics & Gerontology | 872 | 4% | 0% | 64 |
6 | Cell Biology | 194 | 8% | 0% | 115 |
7 | Chemistry, Medicinal | 43 | 2% | 0% | 35 |
8 | Biophysics | 30 | 3% | 0% | 41 |
9 | Medicine, Research & Experimental | 26 | 3% | 0% | 41 |
10 | Cell & Tissue Engineering | 11 | 0% | 0% | 5 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELL BIOL GENE EXP S UNIT | 185032 | 1% | 52% | 17 |
2 | CELL BIOL GENE EXP S SECT | 132245 | 1% | 48% | 13 |
3 | PL NEUROGENET | 127521 | 1% | 46% | 13 |
4 | NEUROGENET | 126868 | 10% | 4% | 148 |
5 | WANGJIANG HOSP | 124286 | 1% | 59% | 10 |
6 | NEUROBIOL GENE THER Y | 115806 | 2% | 22% | 25 |
7 | BOOTH GARDNER PARKINSONS CARE | 108655 | 1% | 43% | 12 |
8 | NEURODEGENERAT EXPT THER EUT | 106462 | 2% | 20% | 25 |
9 | NEUROREGENERAT PROGRAM | 105299 | 1% | 28% | 18 |
10 | RD CELL DESIGN | 88040 | 0% | 83% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PARKINSONISM & RELATED DISORDERS | 52313 | 5% | 3% | 77 |
2 | MOVEMENT DISORDERS | 37769 | 7% | 2% | 108 |
3 | NEUROBIOLOGY OF AGING | 11456 | 4% | 1% | 56 |
4 | HUMAN MOLECULAR GENETICS | 10543 | 5% | 1% | 70 |
5 | NEUROGENETICS | 10077 | 1% | 3% | 17 |
6 | MOLECULAR NEURODEGENERATION | 6374 | 1% | 2% | 13 |
7 | PARKINSONS DISEASE | 6110 | 1% | 3% | 11 |
8 | FRONTIERS IN MOLECULAR NEUROSCIENCE | 4371 | 1% | 2% | 11 |
9 | NEURODEGENERATIVE DISEASES | 3052 | 1% | 1% | 10 |
10 | JOURNAL OF PARKINSONS DISEASE | 2725 | 0% | 2% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LRRK2 | 6227851 | 25% | 81% | 365 | Search LRRK2 | Search LRRK2 |
2 | LEUCINE RICH REPEAT KINASE 2 | 1198062 | 4% | 90% | 63 | Search LEUCINE+RICH+REPEAT+KINASE+2 | Search LEUCINE+RICH+REPEAT+KINASE+2 |
3 | LEUCINE RICH REPEAT KINASE 2 LRRK2 | 827972 | 3% | 85% | 46 | Search LEUCINE+RICH+REPEAT+KINASE+2+LRRK2 | Search LEUCINE+RICH+REPEAT+KINASE+2+LRRK2 |
4 | PARK8 | 826034 | 3% | 95% | 41 | Search PARK8 | Search PARK8 |
5 | G2019S | 676781 | 2% | 97% | 33 | Search G2019S | Search G2019S |
6 | DARDARIN | 455382 | 2% | 86% | 25 | Search DARDARIN | Search DARDARIN |
7 | ATP13A2 | 368111 | 2% | 62% | 28 | Search ATP13A2 | Search ATP13A2 |
8 | PARKINSONS DISEASE | 349320 | 49% | 2% | 704 | Search PARKINSONS+DISEASE | Search PARKINSONS+DISEASE |
9 | G2019S MUTATION | 253561 | 1% | 100% | 12 | Search G2019S+MUTATION | Search G2019S+MUTATION |
10 | KUFOR RAKEB SYNDROME | 223181 | 1% | 81% | 13 | Search KUFOR+RAKEB+SYNDROME | Search KUFOR+RAKEB+SYNDROME |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RUDENKO, I , COOKSON, M , (2014) HETEROGENEITY OF LEUCINE-RICH REPEAT KINASE 2 MUTATIONS: GENETICS, MECHANISMS AND THERAPEUTIC IMPLICATIONS.NEUROTHERAPEUTICS. VOL. 11. ISSUE 4. P. 738 -750 | 155 | 95% | 8 |
2 | WALLINGS, R , MANZONI, C , BANDOPADHYAY, R , (2015) CELLULAR PROCESSES ASSOCIATED WITH LRRK2 FUNCTION AND DYSFUNCTION.FEBS JOURNAL. VOL. 282. ISSUE 15. P. 2806 -2826 | 146 | 87% | 8 |
3 | PAISAN-RUIZ, C , LEWIS, PA , SINGLETON, AB , (2013) LRRK2: CAUSE, RISK, AND MECHANISM.JOURNAL OF PARKINSONS DISEASE. VOL. 3. ISSUE 2. P. 85 -103 | 150 | 91% | 14 |
4 | ESTEVES, AR , SWERDLOW, RH , CARDOSO, SM , (2014) LRRK2, A PUZZLING PROTEIN: INSIGHTS INTO PARKINSON'S DISEASE PATHOGENESIS.EXPERIMENTAL NEUROLOGY. VOL. 261. ISSUE . P. 206 -216 | 135 | 91% | 18 |
5 | LANGSTON, RG , RUDENKO, IN , COOKSON, MR , (2016) THE FUNCTION OF ORTHOLOGUES OF THE HUMAN PARKINSON'S DISEASE GENE LRRK2 ACROSS SPECIES: IMPLICATIONS FOR DISEASE MODELLING IN PRECLINICAL RESEARCH.BIOCHEMICAL JOURNAL. VOL. 473. ISSUE . P. 221 -232 | 118 | 86% | 0 |
6 | TAYMANS, JM , GREGGIO, E , (2016) LRRK2 KINASE INHIBITION AS A THERAPEUTIC STRATEGY FOR PARKINSON'S DISEASE, WHERE DO WE STAND?.CURRENT NEUROPHARMACOLOGY. VOL. 14. ISSUE 3. P. 214 -225 | 93 | 99% | 1 |
7 | MARTIN, I , KIM, JW , DAWSON, VL , DAWSON, TM , (2014) LRRK2 PATHOBIOLOGY IN PARKINSON'S DISEASE.JOURNAL OF NEUROCHEMISTRY. VOL. 131. ISSUE 5. P. 554 -565 | 90 | 91% | 18 |
8 | RIDEOUT, HJ , STEFANIS, L , (2014) THE NEUROBIOLOGY OF LRRK2 AND ITS ROLE IN THE PATHOGENESIS OF PARKINSON'S DISEASE.NEUROCHEMICAL RESEARCH. VOL. 39. ISSUE 3. P. 576-592 | 103 | 79% | 15 |
9 | YUE, M , HINKLE, KM , DAVIES, P , TRUSHINA, E , FIESEL, FC , CHRISTENSON, TA , SCHROEDER, AS , ZHANG, L , BOWLES, E , BEHROUZ, B , ET AL (2015) PROGRESSIVE DOPAMINERGIC ALTERATIONS AND MITOCHONDRIAL ABNORMALITIES IN LRRK2 G2019S KNOCK-IN MICE.NEUROBIOLOGY OF DISEASE. VOL. 78. ISSUE . P. 172 -195 | 87 | 81% | 16 |
10 | GOMEZ-SUAGA, P , FDEZ, E , FERNANDEZ, B , MARTINEZ-SALVADOR, M , RAMIREZ, MB , MADERO-PEREZ, J , RIVERO-RIOS, P , FUENTES, JM , HILFIKER, S , (2014) NOVEL INSIGHTS INTO THE NEUROBIOLOGY UNDERLYING LRRK2-LINKED PARKINSON'S DISEASE.NEUROPHARMACOLOGY. VOL. 85. ISSUE . P. 45 -56 | 101 | 74% | 12 |
Classes with closest relation at Level 1 |